Katayoun Rezvani

23PUBLICATIONS
200CO-AUTHORS
Cell and nuclear divisionMolecular targetsHaematologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Feb 11, 2026
Agent-based modeling of cellular dynamics in adoptive cell therapy.

Yujia Wang, Stefano Casarin, May Daher

|Jan 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei

|Oct 27, 2025
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.

Paul Lin, Sunil Acharya, Francia Reyes-Silva

|Jun 04, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.

Hind Rafei, Rafet Basar, Sunil Acharya

Pageof 4